The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS INC | COM | 35104E100 | 6,250,210 | 308,500 | SH | SOLE | 308,500 | 0 | 0 | ||
ACELYRIN INC | COM | 00445A100 | 30,930,189 | 4,146,138 | SH | SOLE | 4,146,138 | 0 | 0 | ||
ALIGOS THERAPEUTICS INC | COM | 01626L105 | 861,208 | 1,297,000 | SH | SOLE | 1,297,000 | 0 | 0 | ||
APPLIED THERAPEUTICS | COM | 03828A101 | 3,659,875 | 1,092,500 | SH | SOLE | 1,092,500 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 6,330,800 | 1,960,000 | SH | SOLE | 1,960,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 10,853,892 | 263,700 | SH | SOLE | 263,700 | 0 | 0 | ||
BIODESIX | COM | 09075X108 | 784,760 | 426,500 | SH | SOLE | 426,500 | 0 | 0 | ||
BIOHAVEN LTD | COM | G1110E107 | 8,560,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 09075X108 | 2,825,900 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 21,436,112 | 1,257,200 | SH | SOLE | 1,257,200 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 9,288,851 | 3,045,525 | SH | SOLE | 3,045,525 | 0 | 0 | ||
CONTEXT THERAPEUTICS INC | COM | 21077P108 | 1,101,750 | 975,000 | SH | SOLE | 975,000 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS INC | COM | 22663K107 | 10,940,850 | 307,500 | SH | SOLE | 307,500 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 7,647,060 | 699,000 | SH | SOLE | 699,000 | 0 | 0 | ||
ETON PHARMACEUTICALS INC | COM | 29772L108 | 11,080,905 | 2,529,887 | SH | SOLE | 2,529,887 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 877,500 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 2,721,258 | 2,982,200 | SH | SOLE | 2,982,200 | 0 | 0 | ||
GOSSAMER BIO INC | NOTE 5.000% 6/0 | 38341PAA0 | 2,915,112 | 8,000,000 | PRN | SOLE | 8,000,000 | 0 | 0 | ||
HARROW HEALTH INC | COM | 415858109 | 42,784,000 | 3,820,000 | SH | SOLE | 3,820,000 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 11,083,170 | 311,500 | SH | SOLE | 311,500 | 0 | 0 | ||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 3,018,510 | 99,000 | SH | SOLE | 99,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 7,292,610 | 897,000 | SH | SOLE | 897,000 | 0 | 0 | ||
JASPER THERAPEUTICS INC | COM | 471871103 | 3,144,433 | 3,985,340 | SH | SOLE | 3,985,340 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 1,837,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COM | 492327101 | 14,214,200 | 357,500 | SH | SOLE | 357,500 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS LTD | COM CLASS A | G5269C101 | 640,210 | 37,500 | SH | SOLE | 37,500 | 0 | 0 | ||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 2,836,925 | 623,500 | SH | SOLE | 623,500 | 0 | 0 | ||
LIQUIDIA CORPORATION | COM NEW | 53635D202 | 5,353,350 | 445,000 | SH | SOLE | 445,000 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 6,125,245 | 563,500 | SH | SOLE | 563,500 | 0 | 0 | ||
MORPHOSYS AG | SPONSORED ADS | 617760202 | 1,435,500 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 2,964,384 | 265,388 | SH | SOLE | 265,388 | 0 | 0 | ||
NYXOAH S A | SHS | B6S7WD106 | 1,599,872 | 344,800 | SH | SOLE | 344,800 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 27,072,200 | 6,070,000 | SH | SOLE | 6,070,000 | 0 | 0 | ||
PRECIGEN INC | COM | 74017N105 | 1,356,750 | 1,012,500 | SH | SOLE | 1,012,500 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 2,584,211 | 112,700 | SH | SOLE | 112,700 | 0 | 0 | ||
PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 5,048,883 | 2,692,594 | SH | SOLE | 2,692,594 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 3,630,780 | 877,000 | SH | SOLE | 877,000 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 28,041,700 | 610,000 | SH | SOLE | 610,000 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | 1,293,396 | 301,491 | SH | SOLE | 301,491 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM NEW | 87184Q206 | 2,799,492 | 359,370 | SH | SOLE | 359,370 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 37,832,200 | 2,215,000 | SH | SOLE | 2,215,000 | 0 | 0 | ||
TREVI THERAPEUTICS INC | COM | 89532M101 | 3,396,900 | 2,535,000 | SH | SOLE | 2,535,000 | 0 | 0 | ||
UROGEN PHARMA LTD | COM | M96088105 | 4,800,000 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 5,652,000 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 2,815,800 | 1,140,000 | SH | SOLE | 1,140,000 | 0 | 0 | ||
VERASTEM INC | COM NEW | 92337C203 | 1,720,796 | 211,400 | SH | SOLE | 211,400 | 0 | 0 | ||
XOMA CORP DEL | COM NEW | 98419J206 | 4,625,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 |